81
82
Beernink, Rik H. J., Scherjon, Sicco A., Cremers, Thomas I. F. H., van Asselt, Antoinette D.I.
Veröffentlicht in: Beernink , R H J , Scherjon , S A , Cremers , T I F H & van Asselt , A D I 2023 , ' Cost-effectiveness analysis of a first-trimester screening test for preterm preeclampsia in the Netherlands ' , Journal of Reproductive Immunology , vol. 160 , 104141 . https://doi.org/10.1016/j.jri.2023.104141;
2023
Veröffentlicht in: Beernink , R H J , Scherjon , S A , Cremers , T I F H & van Asselt , A D I 2023 , ' Cost-effectiveness analysis of a first-trimester screening test for preterm preeclampsia in the Netherlands ' , Journal of Reproductive Immunology , vol. 160 , 104141 . https://doi.org/10.1016/j.jri.2023.104141;
2023
83
Geurten, Rose J., Struijs, Jeroen N., Elissen, Arianne M. J., Bilo, Henk J. G., van Tilburg, Chantal, Ruwaard, Dirk
Veröffentlicht in: Geurten , R J , Struijs , J N , Elissen , A M J , Bilo , H J G , van Tilburg , C & Ruwaard , D 2022 , ' Delineating the Type 2 Diabetes Population in the Netherlands Using an All-Payer Claims Database : Specialist Care, Medication Utilization and Expenditures 2016-2018 ' , PharmacoEconomics - open , vol. 6 , no. 2 , pp. 219-229 . https://doi.org/10.1007/s41669-021-00308-0;
2022
Veröffentlicht in: Geurten , R J , Struijs , J N , Elissen , A M J , Bilo , H J G , van Tilburg , C & Ruwaard , D 2022 , ' Delineating the Type 2 Diabetes Population in the Netherlands Using an All-Payer Claims Database : Specialist Care, Medication Utilization and Expenditures 2016-2018 ' , PharmacoEconomics - open , vol. 6 , no. 2 , pp. 219-229 . https://doi.org/10.1007/s41669-021-00308-0;
2022
84
Geurten, R.J., Struijs, J.N., Elissen, A.M.J., Bilo, H.J.G., van Tilburg, C., Ruwaard, D.
Veröffentlicht in: Geurten , R J , Struijs , J N , Elissen , A M J , Bilo , H J G , van Tilburg , C & Ruwaard , D 2022 , ' Delineating the Type 2 Diabetes Population in the Netherlands Using an All-Payer Claims Database: Specialist Care, Medication Utilization and Expenditures 2016-2018 ' , PharmacoEconomics - open , vol. 6 , no. 2 , pp. 219-229 . https://doi.org/10.1007/s41669-021-00308-0;
2022
Veröffentlicht in: Geurten , R J , Struijs , J N , Elissen , A M J , Bilo , H J G , van Tilburg , C & Ruwaard , D 2022 , ' Delineating the Type 2 Diabetes Population in the Netherlands Using an All-Payer Claims Database: Specialist Care, Medication Utilization and Expenditures 2016-2018 ' , PharmacoEconomics - open , vol. 6 , no. 2 , pp. 219-229 . https://doi.org/10.1007/s41669-021-00308-0;
2022
85
86
87
88
89
90
Schuttelaar, M L A, Vermeulen, K M, Coenraads, P J
Veröffentlicht in: Schuttelaar , M L A , Vermeulen , K M & Coenraads , P J 2011 , ' Costs and cost-effectiveness analysis of treatment in children with eczema by nurse practitioner vs. dermatologist : results of a randomized, controlled trial and a review of international costs ' , British Journal of Dermatology , vol. 165 , no. 3 , pp. 600-611 . https://doi.org/10.1111/j.1365-2133.2011.10470.x;
2011
Veröffentlicht in: Schuttelaar , M L A , Vermeulen , K M & Coenraads , P J 2011 , ' Costs and cost-effectiveness analysis of treatment in children with eczema by nurse practitioner vs. dermatologist : results of a randomized, controlled trial and a review of international costs ' , British Journal of Dermatology , vol. 165 , no. 3 , pp. 600-611 . https://doi.org/10.1111/j.1365-2133.2011.10470.x;
2011